Literature DB >> 29763403

Cost of Cancer Drugs: Something Has To Give.

Eric Bender.   

Abstract

The drugs often are more effective and have fewer side effects. The science-often just amazing. Medically, cancer treatment has never been in a better place. But are high prices making it unaffordable? Payers, providers, policymakers, and drugmakers themselves are wrestling with the issue. Meanwhile, many patients are being priced out of treatments that could save their lives.

Entities:  

Keywords:  Drug Costs; Health Care Costs; Pharmaceutical Economics; Pharmacoeconomics

Mesh:

Substances:

Year:  2018        PMID: 29763403

Source DB:  PubMed          Journal:  Manag Care        ISSN: 1062-3388


  1 in total

1.  Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related Treatments.

Authors:  K Robin Yabroff; Jingxuan Zhao; Janet S de Moor; Helmneh M Sineshaw; Andrew N Freedman; Zhiyuan Zheng; Xuesong Han; Ashish Rai; Carrie N Klabunde
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.